Navigation Links
CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
Date:5/8/2009

s proprietary CHEF1(R) expression system, process development, analytical and formulation development, and comprehensive analytical testing including long-term stability studies.

As part of CMC Biologics A/S, CMC ICOS offers both stirred tank and perfusion production processes. CMC ICOS is located near Seattle, WA and CMC Biologics is located in Copenhagen, Denmark. www.cmcbio.com

About Implicit Bioscience Ltd

Implicit Bioscience Ltd is a public unlisted Australian biopharmaceutical company based in Brisbane (Australia) and Seattle, WA that develops drugs which modulate the host immune response to disease. Its business model is to mitigate both product risk and capital risk, through the in-licensing and development of clinical stage programs that have known safety profiles in man, and present opportunity for third party non-dilutive funding. Implicit is currently developing oglufanide disodium for the treatment of serious infections including those caused by a variety of biothreat agents (under a contract with the US Defense Threat Reduction Agency). www.implicitbioscience.com

This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, the completion of clinical trials, the FDA review processes and other governmental regulation, Implicit's ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, the ability to effectively market products, and other factors described in Implicit's filings with the Australian Securities and Investment Commission. Implicit does not undertake any duty to update forward-lo
'/>"/>

SOURCE Implicit Bioscience Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
2. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
3. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
4. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
5. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
6. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
7. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
8. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
9. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
10. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
11. SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... YORK , 22 de mayo de ... DPRX ), una compañía farmacéutica de ... comercialización de Locilex® (pexiganan cream 0.8%), y ... una presentación de póster destacando el diseño ... 3 de la Compañía que evalúan Locilex®, ...
(Date:5/22/2015)... 22, 2015 The Assistance Fund announces the ... provides financial assistance for copay to individuals diagnosed with ... the addition of the Melanoma Copay Assistance Program to ... , executive director. "With each additional program we are ... world where no one is denied access to medications ...
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... England, March 8, 2012 Circassia Ltd, ... that its ragweed allergy therapy has achieved positive results ... study, patients with more severe symptoms achieved a significantly ... than those on placebo (p≤0.05).  The results were presented ...
... 8, 2012 Sosei Group Corporation ("Sosei"; ... that its wholly owned Japanese subsidiary, Sosei Co., Ltd., ... for the treatment of oropharyngeal candidiasis. SO-1105 was originally ... received its first marketing authorization for SO-1105 in France ...
Cached Medicine Technology:Circassia's Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results 2Circassia's Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results 3Sosei Announces Initiation of Phase I Study for SO-1105 2
(Date:5/23/2015)... On May 16, the team at Farrell’s eXtreme Bodyshaping ... obstacle run that raised funds for multiple sclerosis. , ... reason we participated was to support people living with MS ... Bodyshaping. “One-hundred percent of the funds raised go to benefit ... only attended by eXtreme Bodyshaping staff, but members of the ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Javon ... at the Sports Medicine and Rehabilitation Center, 557 N. ... program, Mondays, June 1-July 20, 5:30-6:30 pm. , The ... coach, and Laurie Finke, RN, BSN, who will offer ... education on nutrition, running mechanics and show selection and ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 ... technology, communication and capacity are intersecting to create ... across society, the opening speaker at WesternU's 34th ... California Lieut. Gov. Gavin Newsom, a former San ... the keynote speaker at the graduation ceremony for ...
(Date:5/22/2015)... Lehi, Utah (PRWEB) May 22, 2015 Mountain ... will host a ribbon cutting ceremony on Friday, May 29, ... 1 p.m. to 6 p.m. The new medical center, set ... 3000 North Triumph Boulevard, Lehi, UT 84043. , “The ... for our team and the Utah County community,” said Kent ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Following yesterday’s ... sale agreement with US-based health brand Nature’s Way, Marc ... brand. Retention of Ascenta Skin is an integral part ... excited about this opportunity to further develop Ascenta Skin ... , Ascenta Skin is a breakthrough, anti-aging skincare supplement ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... July 21 The Neutraceutical Company, LLC (TNC -- www.tncllc.com ... exclusive rights to direct market a remarkable new extract of an ... ways for centuries. This new, 100% natural product is the latest ... helping people cope with everyday health concerns. , ...
... , , BALTIMORE, July 21 ... to people that want to take control of their health, and ... to employers announced that they have reached an agreement to bring ... their employees - "stay healthy." , , ...
... , LONDON, July 21 Europe,s aging population ... diagnoses of respiratory diseases. While there has been a shift towards ... profit margins in this highly price sensitive market, while providing technologically ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , ...
... , Project SHALEM: Partnering with the Faith-Based ... , BALTIMORE, July 21 Today, the ... at the University of Maryland School of Medicine, in partnership with ... Project SHALEM during City Uprising Baltimore ...
... , , , , ... DGX ), the world,s leading provider of diagnostic testing, ... 30, 2009, income from continuing operations rose to $188 million, or ... share, for the second quarter of 2008. These results include a ...
... , Project SHALEM: Partnering with ... , , BALTIMORE, July 21 ... Virology (IHV) at the University of Maryland School of Medicine, in ... organizations kicked-off Project SHALEM during City Uprising ...
Cached Medicine News:Health News:The Neutraceutical Company Announces Powerful New 'Feel-Good' Product 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 3Health News:Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market 2Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 2Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 3Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 3Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 5Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 6Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 7Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 8Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 9Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 10Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 11Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 12Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 13Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 14Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 2Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 3Health News:JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community 4
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Disposable 1 1/4" Tungsten Micro Needle, Ins., Straight...
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
Medicine Products: